{"id":"https://openalex.org/W2333258704","doi":"https://doi.org/10.1128/aac.00391-16","title":"Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model","display_name":"Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model","publication_year":2016,"publication_date":"2016-04-12","ids":{"openalex":"https://openalex.org/W2333258704","doi":"https://doi.org/10.1128/aac.00391-16","mag":"2333258704","pmid":"https://pubmed.ncbi.nlm.nih.gov/27067321","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4879417"},"language":"en","primary_location":{"id":"doi:10.1128/aac.00391-16","doi":"https://doi.org/10.1128/aac.00391-16","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00391-16","pdf_url":"https://aac.asm.org/content/aac/60/6/3759.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aac.asm.org/content/aac/60/6/3759.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000453333","display_name":"John A. Moss","orcid":"https://orcid.org/0000-0001-8091-3245","observed_orcids":["https://orcid.org/0000-0001-8091-3245"]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John A. Moss","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028920905","display_name":"Irina Butkyavichene","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115989","display_name":"Auritec Pharmaceuticals (United States)","ror":"https://ror.org/024kwpx52","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115989"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irina Butkyavichene","raw_affiliation_strings":["Auritec Pharmaceuticals, Inc., Pasadena, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auritec Pharmaceuticals, Inc., Pasadena, California, USA","institution_ids":["https://openalex.org/I4210115989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077273306","display_name":"Scott A. Churchman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115989","display_name":"Auritec Pharmaceuticals (United States)","ror":"https://ror.org/024kwpx52","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115989"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott A. Churchman","raw_affiliation_strings":["Auritec Pharmaceuticals, Inc., Pasadena, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auritec Pharmaceuticals, Inc., Pasadena, California, USA","institution_ids":["https://openalex.org/I4210115989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075413650","display_name":"Manjula Gunawardana","orcid":"https://orcid.org/0000-0002-3137-8669","observed_orcids":["https://orcid.org/0000-0002-3137-8669"]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manjula Gunawardana","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072333256","display_name":"Rob K. Fanter","orcid":"https://orcid.org/0000-0003-2981-4182","observed_orcids":["https://orcid.org/0000-0003-2981-4182"]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rob Fanter","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059205447","display_name":"Christine S. Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine S. Miller","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059140573","display_name":"Flora Yang","orcid":"https://orcid.org/0000-0002-3934-7437","observed_orcids":["https://orcid.org/0000-0002-3934-7437"]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Flora Yang","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058173965","display_name":"Jeremiah T. Easley","orcid":"https://orcid.org/0000-0002-7294-6407","observed_orcids":["https://orcid.org/0000-0002-7294-6407"]},"institutions":[{"id":"https://openalex.org/I92446798","display_name":"Colorado State University","ror":"https://ror.org/03k1gpj17","country_code":"US","type":"education","lineage":["https://openalex.org/I92446798"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremiah T. Easley","raw_affiliation_strings":["Preclinical Surgical Research Laboratory, Colorado State University, Fort Collins, Colorado, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Surgical Research Laboratory, Colorado State University, Fort Collins, Colorado, USA","institution_ids":["https://openalex.org/I92446798"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082007029","display_name":"Mark A. Marzinke","orcid":"https://orcid.org/0000-0003-1670-8786","observed_orcids":["https://orcid.org/0000-0003-1670-8786"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark A. Marzinke","raw_affiliation_strings":["Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA","Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053567182","display_name":"Craig W. Hendrix","orcid":"https://orcid.org/0000-0002-5696-8665","observed_orcids":["https://orcid.org/0000-0002-5696-8665"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig W. Hendrix","raw_affiliation_strings":["Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101957998","display_name":"Thomas J. Smith","orcid":"https://orcid.org/0000-0002-0978-1494","observed_orcids":["https://orcid.org/0000-0002-0978-1494"]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]},{"id":"https://openalex.org/I4210115989","display_name":"Auritec Pharmaceuticals (United States)","ror":"https://ror.org/024kwpx52","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115989"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Smith","raw_affiliation_strings":["Auritec Pharmaceuticals, Inc., Pasadena, California, USA","Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auritec Pharmaceuticals, Inc., Pasadena, California, USA","institution_ids":["https://openalex.org/I4210115989"]},{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA","institution_ids":["https://openalex.org/I4210086937"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086096371","display_name":"Marc M. Baum","orcid":"https://orcid.org/0000-0003-1558-5649","observed_orcids":["https://orcid.org/0000-0003-1558-5649"]},"institutions":[{"id":"https://openalex.org/I4210086937","display_name":"Oak Crest Institute of Science","ror":"https://ror.org/0006n3612","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210086937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc M. Baum","raw_affiliation_strings":["Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA","institution_ids":["https://openalex.org/I4210086937"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.2288,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.95308815,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"60","issue":"6","first_page":"3759","last_page":"3766"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.5717999935150146,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.5717999935150146,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.35030001401901245,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.057500001043081284,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-pre-exposure-prophylaxis","display_name":"HIV pre-exposure prophylaxis","score":0.9010000228881836},{"id":"https://openalex.org/keywords/tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate","score":0.9890000224113464},{"id":"https://openalex.org/keywords/maraviroc","display_name":"maraviroc","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ccr5-antagonist","display_name":"CCR5 antagonist","score":0.7749999761581421},{"id":"https://openalex.org/keywords/sheep-model","display_name":"sheep model","score":0.671999990940094},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.578000009059906}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7502435445785522},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.6768854856491089},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6615563631057739},{"id":"https://openalex.org/C2778899366","wikidata":"https://www.wikidata.org/wiki/Q421369","display_name":"Maraviroc","level":3,"score":0.6473698616027832},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.644169807434082},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5956781506538391},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4956861734390259},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.4703904390335083},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4549339711666107},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.4480415880680084},{"id":"https://openalex.org/C2779496540","wikidata":"https://www.wikidata.org/wiki/Q7239230","display_name":"Pre-exposure prophylaxis","level":5,"score":0.43691742420196533},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4131457805633545},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.2812793254852295},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26426345109939575},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2350134253501892},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.13497787714004517},{"id":"https://openalex.org/C2776939746","wikidata":"https://www.wikidata.org/wiki/Q853451","display_name":"Men who have sex with men","level":4,"score":0.12005916237831116},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12002027034759521},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.11769455671310425},{"id":"https://openalex.org/C2776983459","wikidata":"https://www.wikidata.org/wiki/Q41083","display_name":"Syphilis","level":3,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000077592","descriptor_name":"Maraviroc","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000282","descriptor_name":"Administration, Intravaginal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003274","descriptor_name":"Contraceptive Devices, Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003510","descriptor_name":"Cyclohexanes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011322","descriptor_name":"Primary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012756","descriptor_name":"Sheep","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014621","descriptor_name":"Vagina","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014621","descriptor_name":"Vagina","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D023421","descriptor_name":"Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.00391-16","doi":"https://doi.org/10.1128/aac.00391-16","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00391-16","pdf_url":"https://aac.asm.org/content/aac/60/6/3759.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4053898","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4879417","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4879417","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4879417","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:27067321","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27067321","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1128/aac.00391-16","doi":"https://doi.org/10.1128/aac.00391-16","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.00391-16","pdf_url":"https://aac.asm.org/content/aac/60/6/3759.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1012123015","display_name":"Intravaginal ring microbicide formulations comprising multiple anti-HIV agents","funder_award_id":"R33AI079791","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G944092896","display_name":"Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention","funder_award_id":"U19AI113048","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W2333258704.pdf"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W645608458","https://openalex.org/W1413161224","https://openalex.org/W1817784777","https://openalex.org/W1898465070","https://openalex.org/W1934467354","https://openalex.org/W1965862717","https://openalex.org/W1968724247","https://openalex.org/W1969813032","https://openalex.org/W1983020368","https://openalex.org/W1991862526","https://openalex.org/W1997866298","https://openalex.org/W1999048558","https://openalex.org/W2000761749","https://openalex.org/W2001213681","https://openalex.org/W2006570914","https://openalex.org/W2015768353","https://openalex.org/W2020699829","https://openalex.org/W2021794886","https://openalex.org/W2022863478","https://openalex.org/W2029667752","https://openalex.org/W2044369525","https://openalex.org/W2046487574","https://openalex.org/W2063191170","https://openalex.org/W2069072974","https://openalex.org/W2078826760","https://openalex.org/W2081356152","https://openalex.org/W2081370497","https://openalex.org/W2095844669","https://openalex.org/W2103920597","https://openalex.org/W2109238714","https://openalex.org/W2117057469","https://openalex.org/W2121288293","https://openalex.org/W2138170968","https://openalex.org/W2140321641","https://openalex.org/W2143206856","https://openalex.org/W2146634980","https://openalex.org/W2148232374","https://openalex.org/W2148553882","https://openalex.org/W2154491542","https://openalex.org/W2159835304","https://openalex.org/W2162226934","https://openalex.org/W2168251450","https://openalex.org/W2171640664","https://openalex.org/W2189403111","https://openalex.org/W2290010664","https://openalex.org/W2291994334","https://openalex.org/W2416499291","https://openalex.org/W2478661965","https://openalex.org/W2593012449"],"related_works":["https://openalex.org/W2171640664","https://openalex.org/W2894262207","https://openalex.org/W1934467354","https://openalex.org/W2416499291","https://openalex.org/W7220739600","https://openalex.org/W7096341231","https://openalex.org/W2143206856","https://openalex.org/W2761054444","https://openalex.org/W2416706976","https://openalex.org/W2888507442"],"abstract_inverted_index":{"Preexposure":[0],"prophylaxis":[1],"(PrEP)":[2],"against":[3],"HIV":[4,44],"using":[5,145],"oral":[6,72],"regimens":[7],"based":[8],"on":[9,49],"the":[10,30,53,109,121,157],"nucleoside":[11],"reverse":[12],"transcriptase":[13],"inhibitor":[14],"tenofovir":[15,172],"disoproxil":[16],"fumarate":[17],"(TDF)":[18],"has":[19],"been":[20],"effective":[21],"to":[22,153,246],"various":[23],"degrees":[24],"in":[25,108,129,164,174],"multiple":[26,84],"clinical":[27,249],"trials,":[28],"and":[29,68,73,90,104,124,214],"CCR5":[31],"receptor":[32],"antagonist":[33],"maraviroc":[34],"(MVC)":[35],"holds":[36],"potential":[37],"for":[38,60,156,171,194,215],"complementary":[39],"efficacy.":[40],"The":[41,88,112],"effectiveness":[42],"of":[43,52,82,95,102,134,178,200],"PrEP":[45],"is":[46,86],"highly":[47],"dependent":[48],"adherence.":[50],"Incorporation":[51],"TDF-MVC":[54],"combination":[55,101],"into":[56,248],"intravaginal":[57],"rings":[58],"(IVRs)":[59],"sustained":[61,115],"mucosal":[62],"delivery":[63],"could":[64],"increase":[65],"product":[66,177],"adherence":[67],"efficacy":[69],"compared":[70],"with":[71,237],"vaginal":[74,165],"gel":[75],"formulations.":[76],"A":[77],"novel":[78,97],"pod-IVR":[79,98,239],"technology":[80],"capable":[81],"delivering":[83,99],"drugs":[85],"described.":[87],"pharmacokinetics":[89],"preliminary":[91],"local":[92],"safety":[93],"characteristics":[94],"a":[96,100],"TDF":[103],"MVC":[105],"were":[106,168,232],"evaluated":[107],"ovine":[110],"model.":[111],"device":[113],"exhibited":[114],"release":[116],"at":[117],"controlled":[118],"rates":[119],"over":[120],"28-day":[122],"study":[123],"maintained":[125],"steady-state":[126,161],"drug":[127,151,162],"levels":[128,163],"cervicovaginal":[130],"fluids":[131],"(CVFs).":[132],"Dilution":[133],"CVFs":[135],"during":[136],"lavage":[137],"sample":[138],"collection":[139],"was":[140],"measured":[141,155],"by":[142],"ion":[143],"chromatography":[144],"an":[146],"inert":[147],"tracer,":[148],"allowing":[149],"corrected":[150],"concentrations":[152],"be":[154],"first":[158],"time.":[159],"Median,":[160],"tissue":[166],"homogenate":[167],"as":[169],"follows:":[170],"(TFV;":[173],"vivo":[175],"hydrolysis":[176],"TDF),":[179],"7.3":[180],"\u00d7":[181,189,192,203,209,212,218,224,227],"10(2)":[182,219],"ng":[183,220],"g(-1)":[184,206,221],"(interquartile":[185],"range":[186],"[IQR],":[187],"3.0":[188],"10(2),":[190,225],"4.0":[191],"10(3));":[193],"TFV":[195],"diphosphate":[196],"(TFV-DP;":[197],"active":[198],"metabolite":[199],"TFV),":[201],"1.8":[202],"10(4)":[204],"fmol":[205],"(IQR,":[207,222],"1.5":[208],"10(4),":[210],"4.8":[211],"10(4));":[213],"MVC,":[216],"8.2":[217],"4.7":[223],"2.0":[226],"10(3)).":[228],"No":[229],"adverse":[230],"events":[231],"observed.":[233],"These":[234],"findings,":[235],"together":[236],"previous":[238],"studies,":[240],"have":[241],"allowed":[242],"several":[243],"lead":[244],"candidates":[245],"advance":[247],"evaluation.":[250]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}